Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses
US6037327A · kind A · utility
23Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 1998 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Aug 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical agent for treating an amyloid disease in a patient, wherein the pharmaceutical agent comprises a saccharide containing at least one substituted anionic group, or a pharmaceutically acceptable salt of the saccharide containing at least one substituted anionic group, and in preferred embodiments is a therapeutically effective amount of glucose pentasulfate. The agent is directed to amyloid diseases in general and to Alzheimer's disease in particular. The pharmaceutical agent may advantageously be combined with a pharmaceutically acceptable carrier, diluent or excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.